• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体神经内分泌肿瘤(PitNETs)研究:基线和系列CT扫描中的真实数据

A Study in Pituitary Neuroendocrine Tumors (PitNETs): Real-Life Data Amid Baseline and Serial CT Scans.

作者信息

Costachescu Mihai, Sima Oana-Claudia, Stanciu Mihaela, Valea Ana, Carsote Mara, Nistor Claudiu, Ciobica Mihai-Lucian

机构信息

Department of Radiology and Medical Imaging, Fundeni Clinical Institute, 022328 Bucharest, Romania.

PhD Doctoral School of "Carol Davila" University of Medicine and Pharmacy, 010825 Bucharest, Romania.

出版信息

Cancers (Basel). 2024 Oct 14;16(20):3477. doi: 10.3390/cancers16203477.

DOI:10.3390/cancers16203477
PMID:39456571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11506321/
Abstract

UNLABELLED

Non-functioning (NF) accidentally detected PitNETs (PIs) are common findings of CT/MRI scans currently. Data concerning their behavior vary, and some PIs will potentially experience a size change over time that might become clinically relevant.

OBJECTIVE

We aimed to evaluate CT-related PIs diameters following 3 aspects: a cross-sectional analysis based on the age' groups at first PI diagnosis and on the gender distribution and a longitudinal analysis in PIs with <0.5 cm versus ≥0.5 cm as the largest diameter at baseline.

METHODS

A retrospective, real-life, multi-centric study in adults with NF micro-PIs was performed.

RESULTS

208 subjects (92.79% females) were included (average age 43.18 ± 12.58 y). The mean largest diameter (between transversal and longitudinal diameters) was 0.55 ± 0.16cm, and 44.71% of the PIs were located on the right part of the pituitary gland. The patients were divided into 10 age-groups (21 to 70 y), and no difference was observed between the mean largest diameters of these groups ( = 0.693). Females and males had a similar age at PIs diagnosis ( = 0.353), transverse diameter ( = 0.910), longitudinal diameter ( = 0.229), and PI location ( = 0.368). Serial CT scans (2 to 4 per patient) included a median (Q1-Q3) of 20 (12-36) months for the second CT scan, 58 (36-84) for the third CT scan, 78 (53-118) for the fourth CT scan, and a total follow-up between baseline and last CT scan of 40 (13-72) months. The initial largest diameter correlated with the diameter change between the baseline and the last CT (r = -0.575, = 0.000). The largest PI diameter was similar between each serial CT scan ( = 0.840). According to the cut-off value of 0.5 cm diameter (for initial largest tumor diameter), group A (N = 78, 37.50%, <0.5 cm) and group B (N = 130, 62. 50%; ≥0.5 cm) had similar age at baseline (43.83 ± 12.72 versus 42.79 ± 12.54 y, = 0.565) and PIs locations (right, left, median). The largest PI diameter remained smaller in group A versus B amid the second CT scan ( = 0.000) and the last CT scan ( = 0.009). The largest diameter change from the first to the last CT scan showed an increase in group A (median of +0.10 cm, = 0.000) and a decrease in group B (median of -0.01 cm, = 0.002); this diameter change was different in group A versus B ( = 0.000). The cumulative probability of tumor-growth-free survival showed different survival functions (log rank = 0.000): group A exhibited a more gradual decrease versus B; at 60 months, the cumulative probability was 0.32 ± 0.08 for group A versus 0.75 ± 0.07 for B. During follow-up, all PIs remained NF, and no hypopituitarism was noted (as limits, we mention that dynamic hypopituitarism testing was selectively performed).

CONCLUSIONS

NF micro-PIs in adults showed a similar age and sex distribution. During follow-up, PIs with a largest diameter < 0.5 cm increased after a median of 40 months but remained <1 cm, while in PIs with ≥0.5 cm, the largest diameter decreased. This highlights a lower predictability in tumor behavior than expected, particularly in larger micro-PIs that, overall, remained without relevant clinical implications after surveillance.

摘要

未标注

无功能(NF)意外发现的垂体神经内分泌肿瘤(PitNETs,PIs)是目前CT/MRI扫描的常见结果。关于其行为的数据各不相同,一些PIs可能会随着时间推移出现大小变化,这可能具有临床相关性。

目的

我们旨在从三个方面评估与CT相关的PIs直径:基于首次PI诊断时的年龄组和性别分布的横断面分析,以及以基线时最大直径<0.5 cm与≥0.5 cm的PIs进行纵向分析。

方法

对患有NF微PIs的成年人进行了一项回顾性、真实世界、多中心研究。

结果

纳入208名受试者(92.79%为女性)(平均年龄43.18±12.58岁)。平均最大直径(横径与纵径之间)为0.55±0.16cm,44.71%的PIs位于垂体右侧。患者分为10个年龄组(21至70岁),这些组的平均最大直径之间未观察到差异(P = 0.693)。女性和男性在PI诊断时年龄相似(P = 0.353),横径(P = 0.910)、纵径(P = 0.229)以及PI位置(P = 0.368)也相似。系列CT扫描(每位患者2至4次)中,第二次CT扫描的时间中位数(四分位数间距)为20(12 - 36)个月,第三次为58(36 - 84)个月,第四次为78(53 - 118)个月,基线至最后一次CT扫描的总随访时间为40(13 - 72)个月。初始最大直径与基线和最后一次CT之间的直径变化相关(r = -0.575,P = 0.000)。每次系列CT扫描之间的最大PI直径相似(P = 0.840)。根据直径0.5 cm的截断值(用于初始最大肿瘤直径),A组(N = 78,37.50%,<0.5 cm)和B组(N = 130,62.50%;≥0.5 cm)在基线时年龄相似(43.83±12.72岁对42.79±12.54岁,P = 0.565)且PI位置(右侧、左侧、中间)相似。在第二次CT扫描(P = 0.000)和最后一次CT扫描(P = 0.009)时,A组的最大PI直径仍小于B组。从第一次到最后一次CT扫描的最大直径变化显示A组增加(中位数为+0.10 cm,P = 0.000),B组减少(中位数为 -0.01 cm,P = 0.002);A组与B组的这种直径变化不同(P = 0.000)。无肿瘤生长生存的累积概率显示出不同的生存函数(对数秩检验P = 0.000):A组与B组相比下降更为缓慢;在60个月时,A组的累积概率为0.32±0.08,B组为0.75±0.07。随访期间,所有PIs仍为NF,未观察到垂体功能减退(作为限制条件,我们提到选择性地进行了动态垂体功能减退测试)。

结论

成人NF微PIs显示出相似的年龄和性别分布。随访期间,最大直径<0.5 cm的PIs在中位40个月后增大但仍<1 cm,而最大直径≥0.5 cm的PIs中,最大直径减小。这突出表明肿瘤行为的可预测性低于预期,特别是在较大的微PIs中,总体而言,监测后仍无相关临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/6a76d82eba04/cancers-16-03477-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/3d333119379f/cancers-16-03477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/e3115588980c/cancers-16-03477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/5c22dea6c2be/cancers-16-03477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/089c62dba1b8/cancers-16-03477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/8172e7a4909e/cancers-16-03477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/7f581abe59d3/cancers-16-03477-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/6a76d82eba04/cancers-16-03477-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/3d333119379f/cancers-16-03477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/e3115588980c/cancers-16-03477-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/5c22dea6c2be/cancers-16-03477-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/089c62dba1b8/cancers-16-03477-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/8172e7a4909e/cancers-16-03477-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/7f581abe59d3/cancers-16-03477-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66e1/11506321/6a76d82eba04/cancers-16-03477-g007.jpg

相似文献

1
A Study in Pituitary Neuroendocrine Tumors (PitNETs): Real-Life Data Amid Baseline and Serial CT Scans.垂体神经内分泌肿瘤(PitNETs)研究:基线和系列CT扫描中的真实数据
Cancers (Basel). 2024 Oct 14;16(20):3477. doi: 10.3390/cancers16203477.
2
A Real-World Longitudinal Study in Non-Functioning Pituitary Incidentalomas: A PRECES Micro-Adenomas Sub-Analysis.一项关于无功能垂体意外瘤的真实世界纵向研究:PRECES微腺瘤亚分析
Diseases. 2024 Oct 2;12(10):240. doi: 10.3390/diseases12100240.
3
Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.非手术治疗后肺癌反应的评估:肿瘤直径、二维乘积和体积。一项基于CT扫描序列的研究。
Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):56-61. doi: 10.1016/s0360-3016(01)01615-7.
4
Evaluating Growth Patterns of Abdominal Aortic Aneurysm Diameter With Serial Computed Tomography Surveillance.评估连续 CT 监测下腹主动脉瘤直径的生长模式。
JAMA Surg. 2021 Apr 1;156(4):363-370. doi: 10.1001/jamasurg.2020.7190.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Different tumor growth pattern of clinically nonfunctioning pituitary neuroendocrine tumor according to sex and age: a longitudinal study.根据性别和年龄的不同,临床无功能垂体神经内分泌肿瘤的生长模式也不同:一项纵向研究。
J Endocrinol Invest. 2024 Aug;47(8):1911-1921. doi: 10.1007/s40618-024-02303-8. Epub 2024 Feb 4.
7
Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk.常规CT扫描下破裂腹主动脉瘤的解剖学特征:对破裂风险的影响
J Vasc Surg. 2004 Jun;39(6):1243-52. doi: 10.1016/j.jvs.2004.02.025.
8
Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.勘误:切除眼柄以增加泥蟹的卵巢成熟度。
J Vis Exp. 2023 May 26(195). doi: 10.3791/6561.
9
Color-flow duplex ultrasound scan versus computed tomographic scan in the surveillance of endovascular aneurysm repair.在血管内动脉瘤修复监测中,彩色血流双功超声扫描与计算机断层扫描的比较
J Vasc Surg. 2003 Oct;38(4):645-51. doi: 10.1016/s0741-5214(03)00909-1.
10
Aberrant Right Subclavian Artery: Demographics, Morphological Features and Follow up CT Scans Dynamics.异常右锁骨下动脉:人口统计学、形态学特征和随访 CT 扫描动态。
Vasc Endovascular Surg. 2024 Feb;58(2):172-177. doi: 10.1177/15385744231203754. Epub 2023 Sep 27.

本文引用的文献

1
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.垂体卒中:对COVID-19时代风险因素及最佳管理策略的重新评估
Pituitary. 2024 Dec;27(6):898-908. doi: 10.1007/s11102-024-01420-0. Epub 2024 Aug 5.
2
[Unification of pathomorphological examination of patients with neuroendocrine tumors of the pituitary gland. Controversial issues of the new classification].[垂体神经内分泌肿瘤患者病理形态学检查的统一。新分类的争议问题]
Probl Endokrinol (Mosk). 2023 Nov 14;70(3):31-45. doi: 10.14341/probl13376.
3
Does New WHO 2022 Nomenclature of Pituitary Neuroendocrine Tumors Offer an Extra Edge to the Neurosurgeons for Its Management? A Narrative Review.
2022年世界卫生组织垂体神经内分泌肿瘤的新命名法是否为神经外科医生在其管理方面提供了额外优势?一项叙述性综述。
Asian J Neurosurg. 2024 Jun 10;19(2):107-111. doi: 10.1055/s-0043-1777264. eCollection 2024 Jun.
4
Clinical implications of the 2022 WHO classification on the multidisciplinary management of PitNETS patients.2022 年世卫组织分类对多学科管理 PitNETS 患者的临床意义。
Minerva Endocrinol (Torino). 2024 Sep;49(3):269-282. doi: 10.23736/S2724-6507.24.04126-5. Epub 2024 Jul 4.
5
Pituitary apoplexy: a systematic review of non-gestational risk factors.垂体卒中:非妊娠相关风险因素的系统综述。
Pituitary. 2024 Aug;27(4):320-334. doi: 10.1007/s11102-024-01412-0. Epub 2024 Jun 27.
6
[Clinically active pituitary tumors].[临床活跃的垂体肿瘤]
Inn Med (Heidelb). 2024 Jul;65(7):672-680. doi: 10.1007/s00108-024-01729-9. Epub 2024 Jun 13.
7
Pituitary Apoplexy: An Updated Review.垂体卒中:最新综述
J Clin Med. 2024 Apr 24;13(9):2508. doi: 10.3390/jcm13092508.
8
Diagnosis and Treatment of Pituitary Apoplexy, A True Endocrine Emergency.垂体卒中的诊断与治疗:真正的内分泌急症。
Arch Med Res. 2024 Jun;55(4):103001. doi: 10.1016/j.arcmed.2024.103001. Epub 2024 May 3.
9
Suggestion of Follow-Up Period in Nonfunctioning Pituitary Incidentaloma Based on MRI Characteristics.基于MRI特征对无功能垂体意外瘤随访期的建议
Brain Tumor Res Treat. 2024 Jan;12(1):40-49. doi: 10.14791/btrt.2023.0046.
10
[Endocrinology: what's new in 2023].[内分泌学:2023年的新进展]
Rev Med Suisse. 2024 Jan 17;20(856-7):36-41. doi: 10.53738/REVMED.2024.20.856-7.36.